Status:

UNKNOWN

Prognostic Implications of Physiologic Investigation After Revascularization With Stent

Lead Sponsor:

Bon-Kwon Koo

Collaborating Sponsors:

Inje University Ilsan Paik Hospital, Goyang, South Korea

Nanjing First Hospital, Nanjing Medical University, Nanjing, China

Conditions:

Coronary Disease

Eligibility:

All Genders

20-100 years

Brief Summary

Percutaneous coronary intervention (PCI) is a standard treatment strategy for coronary artery disease (CAD). With the presence of myocardial ischemia, PCI reduces the risks of death, myocardial infarc...

Detailed Description

This study population was incorporated from studies which were already published. Investigators will incorporate all known registries to the POST-PCI FLOW registry by requesting data from principal in...

Eligibility Criteria

Inclusion

  • Articles were included when they met the following prespecified criteria: (1) included the patients who underwent PCI with drug-eluting stent (DES); (2) post-PCI FFR was measured after DES implantation; (3) pre-PCI FFR measurement was not mandatory for article inclusion; (4) patients were followed up at least 6 months; (5) clinical outcomes, including all-cause death, cardiac death, target vessel myocardial infarction (TVMI) or target vessel revascularization (TVR), were clearly reported; (6) randomized controlled trials or non-randomized prospective or retrospective registries were included. Two independent investigators screened titles and abstracts, identified duplicated studies, performed full-article reviews, and determined the studies' inclusion. The third investigator supervised the searching process and adjudicated all the disagreements.
  • Patients with life expectancy \< 2 years.

Exclusion

    Key Trial Info

    Start Date :

    May 16 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 28 2021

    Estimated Enrollment :

    5100 Patients enrolled

    Trial Details

    Trial ID

    NCT04684043

    Start Date

    May 16 2020

    End Date

    February 28 2021

    Last Update

    February 26 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Seoul National University Hospital

    Seoul, Select, South Korea, 03080